These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28043638)

  • 1. Activity of drugs against dormant Mycobacterium tuberculosis.
    Iacobino A; Piccaro G; Giannoni F; Mustazzolu A; Fattorini L
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S94-S95. PubMed ID: 28043638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fighting tuberculosis by drugs targeting nonreplicating
    Iacobino A; Piccaro G; Giannoni F; Mustazzolu A; Fattorini L
    Int J Mycobacteriol; 2017; 6(3):213-221. PubMed ID: 28776518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium tuberculosis Is Selectively Killed by Rifampin and Rifapentine in Hypoxia at Neutral pH.
    Iacobino A; Piccaro G; Giannoni F; Mustazzolu A; Fattorini L
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditions.
    Piccaro G; Giannoni F; Filippini P; Mustazzolu A; Fattorini L
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1428-33. PubMed ID: 23295931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of DNA-targeted C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates against aerobically and hypoxically grown Mycobacterium tuberculosis under acidic and neutral conditions.
    Iacobino A; Giannoni F; Fattorini L; Brucoli F
    J Antibiot (Tokyo); 2018 Sep; 71(9):831-834. PubMed ID: 29795520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
    Iacobino A; Giannoni F; Pardini M; Piccaro G; Fattorini L
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting dormant bacilli to fight tuberculosis.
    Fattorini L; Piccaro G; Mustazzolu A; Giannoni F
    Mediterr J Hematol Infect Dis; 2013 Nov; 5(1):e2013072. PubMed ID: 24363887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in Caseum.
    Sarathy JP; Xie M; Jones RM; Chang A; Osiecki P; Weiner D; Tsao WS; Dougher M; Blanc L; Fotouhi N; Via LE; Barry CE; De Vlaminck I; Sherman DR; Dartois VA
    mBio; 2023 Apr; 14(2):e0059823. PubMed ID: 37017524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen Modulates the Effectiveness of Granuloma Mediated Host Response to Mycobacterium tuberculosis: A Multiscale Computational Biology Approach.
    Sershen CL; Plimpton SJ; May EE
    Front Cell Infect Microbiol; 2016; 6():6. PubMed ID: 26913242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tedizolid, Faropenem, and Moxifloxacin Combination With Potential Activity Against Nonreplicating
    Srivastava S; Cirrincione KN; Deshpande D; Gumbo T
    Front Pharmacol; 2020; 11():616294. PubMed ID: 33542690
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen.
    Deb C; Lee CM; Dubey VS; Daniel J; Abomoelak B; Sirakova TD; Pawar S; Rogers L; Kolattukudy PE
    PLoS One; 2009 Jun; 4(6):e6077. PubMed ID: 19562030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sterilising action of pyrazinamide in models of dormant and rifampicin-tolerant Mycobacterium tuberculosis.
    Hu Y; Coates AR; Mitchison DA
    Int J Tuberc Lung Dis; 2006 Mar; 10(3):317-22. PubMed ID: 16562713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline.
    Darby CM; Nathan CF
    J Antimicrob Chemother; 2010 Jul; 65(7):1424-7. PubMed ID: 20435781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metronidazole lacks activity against Mycobacterium tuberculosis in an in vivo hypoxic granuloma model of latency.
    Klinkenberg LG; Sutherland LA; Bishai WR; Karakousis PC
    J Infect Dis; 2008 Jul; 198(2):275-83. PubMed ID: 18491971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
    de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
    Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of Drug-Tolerant
    Lanni A; Iacobino A; Fattorini L; Giannoni F
    Microorganisms; 2023 Jun; 11(6):. PubMed ID: 37375013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Novel Anti-mycobacterial Compounds by Screening a Pharmaceutical Small-Molecule Library against Nonreplicating Mycobacterium tuberculosis.
    Warrier T; Martinez-Hoyos M; Marin-Amieva M; Colmenarejo G; Porras-De Francisco E; Alvarez-Pedraglio AI; Fraile-Gabaldon MT; Torres-Gomez PA; Lopez-Quezada L; Gold B; Roberts J; Ling Y; Somersan-Karakaya S; Little D; Cammack N; Nathan C; Mendoza-Losana A
    ACS Infect Dis; 2015 Dec; 1(12):580-5. PubMed ID: 27623055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug targets in dormant Mycobacterium tuberculosis: can the conquest against tuberculosis become a reality?
    Gupta VK; Kumar MM; Singh D; Bisht D; Sharma S
    Infect Dis (Lond); 2018 Feb; 50(2):81-94. PubMed ID: 28933243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential effect of ezetimibe against Mycobacterium tuberculosis infection in type II diabetes.
    Tsai IF; Kuo CP; Lin AB; Chien MN; Ho HT; Wei TY; Wu CL; Lu YT
    Respirology; 2017 Apr; 22(3):559-566. PubMed ID: 27879023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.